RA CAPITAL MANAGEMENT, L.P. Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$3.2T
Holdings
48
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (48 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 4,914,955 | $553.5B | 17.48% | |
| 2 | —RA PHARMACEUTICALS INC | 4,858,260 | $233.2B | 7.37% | |
| 3 | CCXIEURCHEMOCENTRYX INC | 4,176,910 | $167.8B | 5.30% | |
| 4 | ARVNARVINAS INC | 3,672,872 | $148.0B | 4.68% | |
| 5 | —ZOGENIX INC | 5,275,538 | $130.5B | 4.12% | |
| 6 | AXSMAXSOME THERAPEUTICS INC | 1,904,094 | $112.0B | 3.54% | |
| 7 | —EIDOS THERAPEUTICS INC | 2,162,671 | $105.9B | 3.35% | |
| 8 | TGTXTG THERAPEUTICS INC | 10,387,411 | $102.2B | 3.23% | |
| 9 | —SATSUMA PHARMACEUTICALS INC | 4,681,858 | $100.8B | 3.18% | |
| 10 | ALECALECTOR INC | 4,127,348 | $99.6B | 3.15% | |
| 11 | PHATPHATHOM PHARMACEUTICALS INC | 3,707,408 | $95.7B | 3.02% | |
| 12 | KALAKALA PHARMACEUTICALS INC | 10,874,613 | $95.6B | 3.02% | |
| 13 | RYTMRHYTHM PHARMACEUTICALS INC | 5,422,312 | $82.5B | 2.61% | |
| 14 | ETNBGBP89BIO INC | 3,161,214 | $79.8B | 2.52% | |
| 15 | EX9EXELIXIS INC | 4,524,961 | $77.9B | 2.46% | |
| 16 | WVEWAVE LIFE SCIENCES LTD | 7,775,207 | $72.9B | 2.30% | |
| 17 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 7,272,714 | $71.1B | 2.24% | |
| 18 | —MOMENTA PHARMACEUTICALS INC | 2,531,445 | $68.9B | 2.18% | |
| 19 | BDTXBLACK DIAMOND THERAPEUTICS INC | 2,589,904 | $64.6B | 2.04% | |
| 20 | —RETROPHIN INC | 4,166,453 | $60.8B | 1.92% | |
| 21 | ORTXUSDORCHARD THERAPEUTICS PLC | 10,364,658 | $57.0B | 1.80% | |
| 22 | 1K0IGM BIOSCIENCES INC | 982,723 | $55.2B | 1.74% | |
| 23 | VSTMVERASTEM INC | 18,604,651 | $49.1B | 1.55% | |
| 24 | RLMDRELMADA THERAPEUTICS INC | 1,379,988 | $47.1B | 1.49% | |
| 25 | GILDGILEAD SCIENCES INC | 548,000 | $41.0B | 1.29% | |
| 26 | —PREVAIL THERAPEUTICS INC | 3,240,534 | $39.5B | 1.25% | |
| 27 | ARDXARDELYX INC | 6,416,684 | $36.5B | 1.15% | |
| 28 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,165,184 | $34.7B | 1.10% | |
| 29 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 12,541,888 | $34.1B | 1.08% | |
| 30 | CRNXCRINETICS PHARMACEUTICALS INC | 1,961,209 | $28.8B | 0.91% | |
| 31 | SCPHSCPHARMACEUTICALS INC | 3,518,998 | $26.0B | 0.82% | |
| 32 | TREURTRILLIUM THERAPEUTICS INC | 6,361,446 | $25.7B | 0.81% | |
| 33 | STOKSTOKE THERAPEUTICS INC | 1,119,963 | $25.6B | 0.81% | |
| 34 | —IMARA INC | 1,454,348 | $23.3B | 0.74% | |
| 35 | CGENCOMPUGEN LTD | 2,957,434 | $21.5B | 0.68% | |
| 36 | IMGNEURIMMUNOGEN INC | 5,166,303 | $17.6B | 0.56% | |
| 37 | NVCRNOVOCURE LTD | 259,099 | $17.4B | 0.55% | |
| 38 | CNCEEURCONCERT PHARMACEUTICALS INC | 1,858,474 | $16.4B | 0.52% | |
| 39 | SLDBSOLID BIOSCIENCES INC | 4,571,164 | $10.9B | 0.35% | |
| 40 | GRTXGALERA THERAPEUTICS INC | 893,115 | $8.5B | 0.27% | |
| 41 | ASNSUSDX4 PHARMACEUTICALS INC | 602,274 | $6.0B | 0.19% | |
| 42 | PASGPASSAGE BIO INC | 322,630 | $5.1B | 0.16% | |
| 43 | QUREUNIQURE NV | 82,180 | $3.9B | 0.12% | |
| 44 | EPIEURESSA PHARMA INC | 959,300 | $3.8B | 0.12% | |
| 45 | —PORTOLA PHARMACEUTICALS INC | 429,399 | $3.1B | 0.10% | |
| 46 | SELBUSDSELECTA BIOSCIENCES INC | 870,633 | $2.1B | 0.07% | |
| 47 | IM8NINSMED INC | 87,405 | $1.4B | 0.04% | |
| 48 | VCELVERICEL CORP | 100,000 | $917.0M | 0.03% |